Atherosclerosis as a risk factor for benign prostatic hyperplasia

BJU International

Volumn 98, Issue 5, 2006, Pages 1038-1042

  Berger, Andreas P ^a   Bartsch, Georg ^a   Deibl, Martina ^a   Alber, Hannes ^a   Pachinger, Otmar ^a   Fritsche, Gernot ^a   Rantner, Barbara ^a   Fraedrich, Gustav ^a   Pallwein, Leo ^a   Aigner, Fritz ^a   Horninger, Wolfgang ^a   Frauscher, Ferdinand ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Atherosclerosis; BPH; Coronary artery disease; Diabetes mellitus; Peripheral arterial occlusive disease

Indexed keywords

HEMOGLOBIN A1C; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; AGING; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOW; COLOR ULTRASOUND FLOWMETRY; COMPUTER ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; INTERNATIONAL PROSTATE SYMPTOM SCORE; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; QUANTITATIVE ANALYSIS; RISK FACTOR; SCORING SYSTEM; SYMPTOM;

AGED; ATHEROSCLEROSIS; COHORT STUDIES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; HUMANS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSTATE; PROSTATIC HYPERPLASIA; RISK FACTORS;

EID: 33749555795     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2006.06400.x     Document Type: Article

References (27)

1. Ghafar MA, Puchner PJ, Anastasiadis AG, Cabelin MA, Buttyan R. Does the prostatic vascular system contribute to the development of benign prostatic hyperplasia? Curr Urol Rep 2002; 3: 292-6
2. Berger AP, Kofler K, Bektic J et al. Increased growth factor production in a human prostatic stromal cell culture model caused by hypoxia. Prostate 2003; 57: 57-65
3. Thompson MM, Garland C, Barrett-Connor E, Khaw KT, Friedlander NJ, Wingard DL. Heart disease risk factors, diabetes and prostatic cancer in an adult community. Am J Epidemiol 1989; 129: 511-7
4. Michel MC, Mehlburger L, Schumacher H, Bressel HU, Goepel M. Effect of diabetes on lower urinary tract symptoms in patients with benign prostatic hyperplasia. J Urol 2000; 163: 1725-9
5. Buttyan R, Chichester P, Stisser B, Matsumoto S, Ghafar MA, Levin RM. Acute intravesical infusion of a cobalt solution stimulates a hypoxia response, growth and angiogenesis in the rat bladder. J Urol 2003; 169: 2402-6
6. Berger AP, Deibl M, Halpern EJ et al. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia. Diabetologia 2005; 48: 784-9
7. Ellenberg M. Development of urinary bladder dysfunction in diabetes mellitus. Ann Int Med 1980; 92: 321-3
8. Bradley WE. Diagnosis of urinary bladder dysfunction in diabetes mellitus. Ann Int Med 1980; 92: 323-6
9. Kedar RP, Cosgrove DO, Smith IE, Mansi JL, Bamber JC. Breast carcinoma: measurement of tumor response to primary medical therapy with color Doppler flow imaging. Radiology 1994; 190: 825-30
10. Fein M, Delorme S, Weisser G, Zuna I, van Kaick G. Quantification of color Doppler for the evaluation of tissue vascularization. Ultrasound Med Biol 1995; 21: 1013-9
11. Cheng WF, Lee CN, Chu JS et al. Vascularity index as a novel parameter for the in vivo assessment of angiogenesis in patients with cervical carcinoma. Cancer 1999; 85: 651-7
12. Nelson TR, Pretorius DH. The Doppler signal: where does it come from and what does it mean? AJR Am J Roentgenol 1988; 151: 439-47
13. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-30
14. Holtgrewe HL, Mebust WK, Dowd JB, Cockett AT, Peters PC, Proctor C. Transurethral prostatectomy: practice aspects of the dominant operation in American urology. J Urol 1989; 141: 248-53
15. Arrighi HM, Metter EJ, Guess HA, Fozzard JL. Natural history of benign prostatic hyperplasia and risk of prostatectomy. The Baltimore Longitudinal Study of Aging. Urology 1991; 38 (Suppl. 1): 4-8
16. Hammarsten J, Hoegstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001; 39: 151-8
17. Taniwaki H, Kawagishi T, Emoto M et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 1999; 22: 1851-7
18. Zimarino M, Cappellatti L, Venarucci V et al. Age-dependence of risk factors for carotid stenosis: an observational study among candidates for coronary arteriography. Atherosclerosis 2001; 159: 165-73
19. McNeal JE. Regional morphology and pathology of the prostate. Am J Clin Pathol 1968; 49: 347-57
20. McNeal JE. Origin and evolution of benign prostatic enlargement. Invest Urol 1978; 15: 340-5
21. Tsuru N, Kurita Y, Masuda H, Suzuki K, Fujita K. Role of Doppler ultrasound and resistive index in benign prostate hypertrophy. Int J Urol 2002; 9: 427-30
22. 2 in healthy probands and patients with arterial ischemia. Adv Exp Med Biol 1987; 220: 235-40
23. Schuster A, Pinggera G, Pallwein L, Frauscher F. Assessment of transrectal color Doppler ultrasound (TRCDUS) for measurement of urinary bladder neck blood flow in a porcine model: comparison to laser Doppler flowmetry. Eur Radiol Suppl 2003; 1: #315
24. Palmer LA, Semenza GL, Stoler MH, Johns RA. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Physiol 1998; 274: L212-9
25. Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002; 2: 38-47
26. Kashiwagi B, Shibata Y, Ohki K. Chronic ischemia induces abnormal growth in the ventral prostate of the rats. J Urol 2005; 173: A1450
27. Montorsi P, Ravagnani PM, Galli S et al. The artery size hypothesis: a macrovascular link between erectile dysfunction and coronary artery disease. Am J Cardiol 2005; 96: 19M-23M